METHODS USED FOR THE APPLICABILITY OF REAL-WORLD DATA SOURCES TO INDIVIDUAL PATIENT DECISION MAKING

被引:1
|
作者
Brnabic, A. [1 ]
Hess, L. M. [2 ]
Carter, Cuyun G. [2 ]
Robinson, R. [2 ]
Araujo, A. B. [3 ]
Swindle, R. [2 ]
机构
[1] Eli Lilly & Co, Sydney, NSW, Australia
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] ELI Lilly, Indianapolis, IN USA
关键词
D O I
10.1016/j.jval.2018.07.773
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRM58
引用
收藏
页码:S102 / S102
页数:1
相关论文
共 50 条
  • [41] DECISION-MAKING EXPERIMENTS AND REAL-WORLD CHOICE BEHAVIOR
    TIMMERMANS, H
    VANDERHEYDEN, R
    WESTERVELD, H
    GEOGRAFISKA ANNALER SERIES B-HUMAN GEOGRAPHY, 1984, 66 (01) : 39 - 48
  • [42] The applicability of the perturbation based privacy preserving data mining for real-world data
    Liu, Li
    Kantarcioglu, Murat
    Thuraisingham, Bhavani
    DATA & KNOWLEDGE ENGINEERING, 2008, 65 (01) : 5 - 21
  • [43] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [44] Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making
    Alnofal, Fatemah A.
    Alrwisan, Adel A.
    Alshammari, Thamir M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1303 - 1306
  • [45] Multidimensional Evidence Generation and FDA Regulatory Decision Making Defining and Using "Real-World" Data
    Jarow, Jonathan P.
    LaVange, Lisa
    Woodcock, Janet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (08): : 703 - 704
  • [46] Development of audit readiness considerations of real-world data for use in regulatory decision-making
    Atzinger, Christopher B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 411 - 411
  • [47] CONTEXT MATTERS - A TAXONOMY OF REAL-WORLD DATA AND EVIDENCE TO SUPPORT HTA DECISION-MAKING
    Murphy, L. A.
    Mestre-Ferrandiz, J.
    Sola-Morales, O.
    de Pouvourville, G.
    Cunningham, D.
    Corry, S.
    Akehurst, R.
    VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [48] Lessons for regulatory decision-making from real-world data trial emulation results
    Wang, Shirley
    Schneeweiss, Sebastian
    Crown, William
    Ross, Joseph
    Arlett, Peter
    Quinto, Kenneth
    Uyama, Yoshiaki
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 8 - 8
  • [49] Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real-World Setting
    Quan, Hui
    Li, Tong
    Chen, Xun
    Li, Gang
    PHARMACEUTICAL STATISTICS, 2025, 24 (01)
  • [50] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1